Pipeline
Oncology: Multi-targeted Antigen Specific T Cells Loaded with Cytokine (Autologous Cell Therapy)
Candidate
Discovery
IND Enabling
Phase 1
Phase 2
Phase 3
Antigen Set 1.0 (Melanoma)
RPTR 147:1 (IL-15 loaded MTC)
Stage: Phase 1
Antigen Set 1.0 (Melanoma)
RPTR 168:1 (IL-12 loaded MTC)
Stage: Phase 1
Antigen Set 2.0 (HPV16+ tumors)
RPTR 147:2 (IL-15 loaded MTC)
Stage: Phase 1
Antigen Set 2.0 (HPV16+ tumors)
RPTR 168:2 (IL-12 loaded MTC)
Stage: Phase 1
IL-15 / IL-12 Combination
(Solid Tumor)
Stage: IND Enabling
Oncology: T Cell Targeted Cytokine Injectable Therapy
Candidate
Discovery
IND Enabling
Phase 1
Phase 2
Phase 3
T Cell Targeted IL-12 (Solid Tumor)
Stage: IND Enabling